Skip to Content

BG-12 240 mg (Dimethyl Fumarate Delayed-Release 240 mg)

Pill with imprint BG-12 240 mg is Green, Capsule-shape and has been identified as Dimethyl Fumarate Delayed-Release 240 mg. It is supplied by Teva Pharmaceuticals USA, Inc..

Dimethyl fumarate is used in the treatment of multiple sclerosis and belongs to the drug class selective immunosuppressants. Risk cannot be ruled out during pregnancy. Dimethyl fumarate 240 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for BG-12 240 mg

Dimethyl fumarate delayed-release 240 mg BG-12 240 mg

Dimethyl Fumarate Delayed-Release

BG-12 240 mg
240 mg
Prescription only
Drug Class
Selective immunosuppressants
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA, Inc.
National Drug Code (NDC)

Get help with Imprint Code FAQs.

Related Images for "BG-12 240 mg"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.